Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

NCT00002105 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Doxorubicin hydrochloride (liposomal)
DRUG: Bleomycin sulfate
DRUG: Vincristine sulfate

Sponsor

Sequus Pharmaceuticals